Other official information and services: www.belgium.be  belgium

Antiarrhythmics (class I & III)

Key figures

PRESCRIBERS
Main prescribers: General practitioners 75.61%
INSURED CONSUMERS
% of insured consumers 1.24%
Median age 76 years
Max/min ratio of the median age (by district) 1.04
Percentage of women 49.72%
Ratio Preferential scheme/General scheme 1.11
Coefficient of variation (2023) 27.91
Max/min ratio of % of insured consumers (by district) 2.55
CONSUMPTION
Annual consumption (DDD) 32,239,971
Consumption of DDD (per 100,000 insured persons) 279,848.59
% DDD issued outside the insurance (approximate) 1.87%
Average annual consumption per insured consumer (DDD) 224.81
% of insured consumers with > 3 times the average consumption 0,47%
Coefficient of variation 2013-2015 32.98
Coefficient of variation 2021-2023 30.41
Trend 2013-2023 -1.55%
Trend 2013-2021 -1.53%
Trend 2021-2023 -1.67%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance 10,205,346 €
Average annual expenditure per insured person 0.89 €
Average patient share per insured consumer 22.61%
Max/min ratio of expenditure per insured person (by disctrict) 2.52
% “Low-cost” medication 55.50%
Trend 2013-2023 -0.45%
Trend 2021-2023 -0.30%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on a yellow background, otherwise on a grey background.

Download the full report

Download the methodology